PARP inhibitors represent an important new class of anticancer agents that are having a major impact on ovarian cancer treatment. These drugs target vulnerabilities in DNA damage response and repair pathways especially in cancer cells that have defects in BRCA and related genes. In an important clinical development announced April 6, 2018, the FDA expanded […]
The Rivkin Center’s CanCan Program The Rivkin Center for Ovarian Cancer’s CanCan program provides free health education workshops. CanCan facilitators help educate women about their health, and about their breast and ovarian cancer risks. Say hello to Gail Fay, CanCan instructor. About Gail Where are you from? Burbank, California Where do you live now […]
Guest blogger Carol Reed shares the story of when she was diagnosed with ovarian cancer. Each woman’s ovarian cancer story is unique, and Carol emphasizes that she speaks only for herself. This is her experience.
Jim Harting left the Rivkin Center the proceeds of the sale of his farm, and the $536,000 gift that Rivkin received this spring as a result of this bequest became one of the largest single gifts in our organization’s history.
Rita was in the middle of battling ovarian cancer and wanted to help others in a meaningful way. She donated a basket full of goodies she thought someone would enjoy.